A
recent study found that double bonuses for Medicare Advantage (MA) plans are
not an efficient mechanism to improve the program, and are not equitable in
allocation of those dollars, disproportionally benefiting White beneficiaries
relative to Black beneficiaries, without improving quality or enrollment. The
report “Medicare Advantage Plan Double Bonuses Drive Racial
Disparity In Payments, Yield No Quality Or Enrollment Improvements,”
was published in September 2021 Health
Affairs.
The
Health Affairs
study describes double bonuses in the MA program: “An unusual feature of the MA
bonus program is the delineation of ‘double-bonus’ counties. In these counties,
higher-quality plans receive certain MA bonuses at double the dollar level paid
to comparably performing plans in counties that are ineligible for double bonuses.
Through the ACA, Congress created three criteria that a county must meet to be
eligible for double bonuses: historically high MA enrollment (at least
25 percent in 2009); low Medicare fee-for-service spending (below the
national average in a given year); and a 2004 ‘urban floor’ designation, given
to Metropolitan Statistical Areas (MSAs) with at least 250,000 residents that
qualify for the minimum MA benchmark rate and granted to areas with low
fee-for-service spending. Although the proportion of counties qualifying for
double-bonus status is small, at around 7 percent of counties nationally,
the impact of their double bonus status is large because 27 percent of MA
beneficiaries live in them, based on our analysis of Medicare data.”
The
study found that Black beneficiaries were substantially less likely to reside
in counties offered double bonuses than White beneficiaries, contributing to
racial disparities in the allocation of double bonus dollars, disfavoring Black
beneficiaries. The study notes that because CMS expects some of the
quality bonus payments to be passed on to beneficiaries through assistance with
Medicare premiums or additional benefits, differences in the allocation of MA
bonus payments to counties that are eligible and not eligible for double
bonuses could result in racial and geographic disparities. These could include
difference in availability of enhanced benefits, or “translate to higher
premiums for the same benefits when offered to primarily Black versus primarily
White populations, which could harm the financial well-being of Black
beneficiaries.”
Another
report released this week also raises questions about MA payments. HHS OIG’s
report, “Some Medicare Advantage Companies Leveraged Chart Reviews
and Health Risk Assessments To Disproportionately Drive Payments,”
reviews risk-adjusted payments to Medicare Advantage companies. The report was
undertaken “because of concerns that MA companies may leverage both chart
reviews and HRAs to maximize risk adjusted payments, without beneficiaries
receiving care for those diagnoses.”
The
OIG report’s recommendations:
“CMS should (1) provide oversight of the 20 MA companies that had a disproportionate share of the risk-adjusted payments from chart reviews and HRAs; (2) take additional actions to determine the appropriateness of payments and care for the 1 MA company that substantially drove risk adjusted payments from chart reviews and HRAs; and (3) perform periodic monitoring to identify MA companies that had a disproportionate share of risk adjusted payments from chart reviews and HRAs. To assist CMS with its efforts, we will provide information on which companies had a substantially disproportionate share of risk adjusted payments from diagnoses that were reported only on chart reviews and/or HRAs. CMS neither concurred nor nonconcurred with our three recommendations and stated that it will take our recommendations under consideration as part of its ongoing process to determine policy options for future years.”
No comments:
Post a Comment